| About the author: |
I. O. Komarevtseva, A. Yu. Ihnatova, I. V. Rudenko, I. V. Kalinin, O. A. Zhurba, K. V. Balabanova, V. N. Komarevtsev |
| Heading |
CLINICAL MEDICINE |
| Type of article |
Scentific article |
| Annotation |
Sphingosine has been shown to prevent and eliminate bacterial infections of the respiratory tract, but it is unknown whether sphingosine can be also employed to prevent viral infections. The involvement in lung injury and endothelial barrier function, sphingosine-1-phosphate could be a potential biomarker of community-acquired pneumonia and COVID-19. The purpose of the study was to determine the diagnostic and prognostic value of sphingosine-1-phosphate and to unravel the complex role of sphingosine-1-phosphate in the pathophysiological pathways of community-acquired pneumonia and COVID-19 in conditions of hyperglycemia. Survival analysis (the advent of severe acute respiratory syndrome within 30 days of hospitalization) was performed using the Kaplan–Meier method; univariate analys were undertaken using log rank test and Cox’s regression model, respectively.
Sphingosine-1-phosphate levels were approximately 2–2.5 times lower in women and men with pneumonia associated with hyperglycemia, Type 2 Diabetes and COVID-19. Moreover, this decrease was greater in men than in women. Sphingosine-1-phosphate is a biomarker of development of severe acute respiratory syndrome within 30 days of hospitalization in patients with COVID-19, community-acquired pneumonia (with and without hyperglycemia and Type 2 Diabetes). |
| Tags |
COVID-19,community-acquired pneumonia,sphingosine-1-phosphate |
| Bibliography |
- Ali-Berrada S, Guitton J, Tan-Chen S, Gyulkhandanyan A, Hajduch E, Le Stunff H. Circulating Sphingolipids and Glucose Homeostasis: An Update. Int J Mol Sci. 2023; 24(16). doi:10.3390/ijms241612720
- Berezniakov VI, Korzh AN, Pavlov SB, Yeroshenko GA, Shevchenko KV, Pyvovar NM. Cytokines as mediators of the immune system and their role In the pathogenesis of community-acquired pneumonia. World of Medicine and Biology. 2021; 77(3):33–37. doi: 10.26724/2079-8334-2021-3-77-33-37
- Edwards MJ, Becker KA, Gripp B, et al. Sphingosine prevents binding of SARS-CoV-2 spike to its cellular receptor ACE2. J Biol Chem. 2020;295(45):15174-15182. doi:10.1074/jbc.RA120.015249
- Hannun YA, Obeid LM. Sphingolipids and their metabolism in physiology and disease. Nat Rev Mol Cell Biol. 2018; 19:175–91.
- Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020;181:271–280.e8. doi: 10.1016/j.cell.2020.02.052.
- Huch T, Shakeri-Nejad K, Bigaud M. Rationale for Use of Sphingosine-1-Phosphate Receptor Modulators in COVID-19 Patients: Overview of Scientific Evidence. J Interferon Cytokine Res. June 2023; 43(6): 246–256. doi: 10.1089/jir.2022.0078
- Hsu S-C, Chang J-H, HsuY-P, Bai K-J, Huang S-K, and Hsu C-W. Circulating sphingosine-1-phosphate as a prognostic biomarker for community-acquired pneumonia. PLoS One. 2019; 14(5). http://www.embase.com/search/results?subaction=viewrecord& from=export&id=L2002002775 %0 Ahttp: //dx.doi.org/10.1371/journal.pone.0216963
- Karam M, Auclair C. Sphingosine-1-Phosphate as Lung and Cardiac Vasculature Protecting Agent in SARS-CoV-2 Infection. Int J Mol Sci. 2023;24(17). doi:10.3390/ijms241713088
- Komarevtseva I, Ihnatova A, Rudenko I, Balabanova K, Komarevtsev V. Liquid biopsy as a tool for predicts of severe COVID- 19 and hospitalised community-acquired pneumonia. Pol. Merkur. Lek (Pol Med J), 2022; L (297); 155–159.
- Liao Y-H, Zheng J-Q, Cai-Mei Zheng C-M, et al. Novel Molecular Evidence Related to COVID-19 in Patients with Diabetes Mellitus. J Clin Med. 2020; 9(12): 3962. doi: 10.3390/jcm9123962
- Marfia G, Navone S, Guarnaccia L. Decreased serum level of sphingosine-1-phosphate: a novel predictor of clinical severity in COVID-19. EMBO Mol Med. 2021;13(1). doi:10.15252/emmm.202013424
- McGowan EM, Haddadi N, Nassif NT, Lin Y. Targeting the SphK-S1P-SIPR Pathway as a Potential Therapeutic Approach for COVID-19. Int J Mol Sci. 2020; 21(19): 7189. doi: 10.3390/ijms21197189
- Nagahashi M, Yamada A, Miyazaki H, Allegood JC, Tsuchida J, Aoyagi T, et. al. Interstitial Fluid Sphingosine-1-Phosphate in Murine Mammary Gland and Cancer and Human Breast Tissue and Cancer Determined by Novel Methods. J Mammary Gland Biol Neoplasia. 2016 Jun; 21(1-2): 9–17. doi: 10.1007/s10911-016-9354-7
- Toro DM, da Silva-Neto PV, de Carvalho JCS. Plasma Sphingomyelin Disturbances: Unveiling Its Dual Role as a Crucial Immunopathological Factor and a Severity Prognostic Biomarker in COVID-19. Cells. 2023;12(15). doi:10.3390/cells12151938
- Torretta E, Garziano M, Poliseno M, Capitanio D, Biasin M, Santantonio TA, et al. Severity of COVID-19 Patients Predicted by Serum Sphingolipids Signature. Int. J. Mol. Sci. 2021;22:10198. doi: 10.3390/ijms221910198.
|
| Publication of the article |
«World of Medicine and Biology» №4(86), 2023 year, 079-085 pages, index UDK 616.61-006:616.65+576.367 |
| DOI |
10.26724/2079-8334-2023-4-86-79-85 |
